Rapid structural discrimination of IgG antibodies by multicharge-state collision-induced unfolding. Issue 58 (12th November 2021)

• Record Type: Journal Article
• Authors: Yin, Zhibin; Du, Mingyi; Chen, Dong; Zhang, Wenyang; Huang, Wenjie; Wu, Xinzhou; Yan, Shijuan
• Is Part Of: RSC advances. Volume 11:Issue 58(2021)
• Page Start: 36502
• Page End: 36510
• Publication Date: 2021-11-12
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d1ra06486j
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : A simplified multicharge-state collision-induced unfolding (CIU) method was proposed for rapid differentiation of IgG isotypes that differ in terms of the numbers and patterns of disulfide bonds. Abstract : Immunoglobulin G (IgG) antibodies are an important class of biotherapeutics that target various diseases, such as cancers, neurodegenerative disorders, and autoimmune diseases, yet rapid discrimination of IgG antibodies remains a great challenge due to heterogeneity, flexibility, and large size. Herein, we demonstrate a simplified multicharge-state collision-induced unfolding (CIU) method for rapid differentiation of four IgG isotypes that differ in terms of the numbers and patterns of disulfide bonds, bypassing tedious single charge-state selection in advance. The results presented herein reveal that gas-phase unfolding behaviors have a strong dependence on charge states outside IgG surfaces; therefore, multicharge-state CIU analysis of IgG subtypes could offer a great opportunity to gain deeper insights into their gas-phase structural differentiation. The full discrimination of IgG antibody isoforms that possess different disulfide bond numbers and even subtle disulfide bonding patterns can be achieved based on their charge-dependent gas-phase unfolding behaviors and root-mean square deviation in CIU difference spectra. Taken together, the incorporation of all charge states observed in a native ion mobility-mass spectrometry (IM-MS) experiment to CIU analysis could make this strategy sensitive to more subtle structural discrepancies, facilitating the rapid discrimination and evaluation of innovative structurally similar biotherapeutic candidates with unexplored functions.